Canopy Growth (NASDAQ:CGC) Stock Moved Up to “Hold” by Wall Street Zen

Wall Street Zen upgraded shares of Canopy Growth (NASDAQ:CGC) from a sell rating to a hold rating in a research note released on Saturday,Wall Street Zen reports.

Separately, Weiss Ratings lowered shares of Canopy Growth from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, September 16th. Two analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold”.

Canopy Growth Stock Up 1.3%

NASDAQ:CGC opened at $0.94 on Friday. The firm has a market capitalization of $423.02 million, a price-to-earnings ratio of -2.09 and a beta of 0.83. Canopy Growth has a 1-year low of $0.84 and a 1-year high of $2.38. The company has a current ratio of 3.04, a quick ratio of 2.39 and a debt-to-equity ratio of 0.31. The business’s fifty day moving average price is $0.96 and its 200 day moving average price is $1.01.

Canopy Growth (NASDAQ:CGC) last announced its quarterly earnings data on Friday, August 7th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.02. Canopy Growth had a negative return on equity of 21.91% and a negative net margin of 65.33%.The firm had revenue of $142.62 million during the quarter, compared to the consensus estimate of $58.21 million. On average, sell-side analysts forecast that Canopy Growth will post -0.1 earnings per share for the current fiscal year.

Institutional Trading of Canopy Growth

Several hedge funds and other institutional investors have recently modified their holdings of CGC. Royal Bank of Canada grew its stake in Canopy Growth by 1,115.6% in the first quarter. Royal Bank of Canada now owns 975,967 shares of the company’s stock valued at $927,000 after purchasing an additional 895,680 shares in the last quarter. Lazard Asset Management LLC acquired a new position in Canopy Growth in the 1st quarter worth about $1,716,000. Caitong International Asset Management Co. Ltd raised its stake in shares of Canopy Growth by 723.5% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 4,595,330 shares of the company’s stock worth $5,239,000 after purchasing an additional 4,037,281 shares in the last quarter. Finally, Foundations Investment Advisors LLC purchased a new stake in shares of Canopy Growth during the 4th quarter worth about $485,000. 3.33% of the stock is currently owned by hedge funds and other institutional investors.

Canopy Growth News Roundup

Here are the key news stories impacting Canopy Growth this week:

• Positive Sentiment: Wall Street Zen raised CGC’s rating to “Hold,” an improvement from its previous recommendation and a modestly more favorable signal for investor sentiment. Canopy Growth stock rating raised to Hold
• Neutral Sentiment: Canopy Growth’s shares finished higher than the broader market in the latest trading session. The reports primarily describe the market performance rather than identify a new operating or financial catalyst. Canopy Growth rises higher than market
• Neutral Sentiment: The company’s 2026 annual general and special meeting will reconvene on October 23 after shareholders failed to provide the required quorum. The voting deadline was extended, giving investors additional time to submit votes. Canopy Growth annual meeting adjournment
• Negative Sentiment: The lack of quorum creates short-term uncertainty around shareholder resolutions and suggests limited investor participation. Although the adjournment is procedural rather than a change to the company’s operations, it may weigh on sentiment until the meeting is completed. Canopy Growth adjourns annual meeting

About Canopy Growth

Canopy Growth Corporation is a cannabis company headquartered in Smiths Falls, Ontario, Canada. Founded in 2013 as Tweed Marijuana Inc, the company adopted the Canopy Growth name in 2015 and has developed a portfolio of cannabis brands serving both adult-use and medical markets.

Canopy Growth’s products include dried cannabis flower, pre-rolls, cannabis oils, softgels, edibles, beverages and vaporization products. Its brand portfolio has included Tweed, 7ACRES, Doja, Deep Space and other cannabis brands, as well as Storz & Bickel vaporization products.